Literature DB >> 16827565

Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation.

Yang Xu1, Hong Lu, Jack P Kennedy, Xuxia Yan, Laura A McAllister, Noboru Yamamoto, Jason A Moss, Grant E Boldt, Shibo Jiang, Kim D Janda.   

Abstract

Protein-protein interactions are of critical importance in biological systems, and small molecule modulators of such protein recognition and intervention processes are of particular interest. To investigate this area of research, we have synthesized small-molecule libraries that can disrupt a number of biologically relevant protein-protein interactions. These library members are designed upon planar motif, appended with a variety of chemical functions, which we have termed "credit-card" structures. From two of our "credit-card" libraries, a series of molecules were uncovered which act as inhibitors against the HIV-1 gp41 fusogenic 6-helix bundle core formation, viral antigen p24 formation, and cell-cell fusion at low micromolar concentrations. From the high-throughput screening assays we utilized, a selective index (SI) value of 4.2 was uncovered for compound 2261, which bodes well for future structure activity investigations and the design of more potent gp41 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827565      PMCID: PMC2529179          DOI: 10.1021/cc0600167

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  35 in total

1.  Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.

Authors:  M Ferrer; T M Kapoor; T Strassmaier; W Weissenhorn; J J Skehel; D Oprian; S L Schreiber; D C Wiley; S C Harrison
Journal:  Nat Struct Biol       Date:  1999-10

Review 2.  Small molecule antagonists of proteins.

Authors:  Thomas R Gadek; John B Nicholas
Journal:  Biochem Pharmacol       Date:  2003-01-01       Impact factor: 5.858

Review 3.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 4.  Anatomy of hot spots in protein interfaces.

Authors:  A A Bogan; K S Thorn
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

Review 5.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

6.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

7.  HIV-1 inhibition by a peptide.

Authors:  S Jiang; K Lin; N Strick; A R Neurath
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

8.  A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

Authors:  S Jiang; K Lin; L Zhang; A K Debnath
Journal:  J Virol Methods       Date:  1999-06       Impact factor: 2.014

9.  The entry of entry inhibitors: a fusion of science and medicine.

Authors:  John P Moore; Robert W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 10.  High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.

Authors:  Shuwen Liu; Shibo Jiang
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  10 in total

1.  A molecular link between the active component of marijuana and Alzheimer's disease pathology.

Authors:  Lisa M Eubanks; Claude J Rogers; Albert E Beuscher; George F Koob; Arthur J Olson; Tobin J Dickerson; Kim D Janda
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

2.  Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.

Authors:  Guangyan Zhou; Dong Wu; Beth Snyder; Roger G Ptak; Harmeet Kaur; Miriam Gochin
Journal:  J Med Chem       Date:  2011-10-03       Impact factor: 7.446

Review 3.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

4.  Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model.

Authors:  Gabriela Mustata; Ariele Viacava Follis; Dalia I Hammoudeh; Steven J Metallo; Huabo Wang; Edward V Prochownik; John S Lazo; Ivet Bahar
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

5.  Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.

Authors:  Yong Wang; Hong Lu; Qiang Zhu; Shibo Jiang; Yun Liao
Journal:  Bioorg Med Chem Lett       Date:  2009-11-05       Impact factor: 2.823

Review 6.  Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Authors:  Lu Lu; Fei Yu; Lifeng Cai; Asim K Debnath; Shibo Jiang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

7.  Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion.

Authors:  Toni Kline; Heather B Felise; Kathleen C Barry; Stona R Jackson; Hai V Nguyen; Samuel I Miller
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

8.  Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail.

Authors:  Jiyang Jiang; Christopher Aiken
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

9.  Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy.

Authors:  Zhiru Li; Amanda L Garner; Christian Gloeckner; Kim D Janda; Clotilde K Carlow
Journal:  PLoS Negl Trop Dis       Date:  2011-11-29

10.  Vpu matchmakers as a therapeutic strategy for HIV infection.

Authors:  Mauricio Montal
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.